PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Ophthalmology10.3341/kjo.2016.00352017313230Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment OutcomesHyun Ji Hwang, Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kimhttps://synapse.koreamed.org/pdf/10.3341/kjo.2016.0035, https://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2016.0035, https://synapse.koreamed.org/DOIx.php?id=10.3341/kjo.2016.0035
10.21203/rs.3.rs-1317439/v12022Ethnic Differences on Long Term Outcomes of Polypoidal Choroidal Vasculopathy after Predominantly Bevacizumab Monotherapy.Aaron Yap, Nancy Wang, David Squirrellhttps://www.researchsquare.com/article/rs-1317439/v1, https://www.researchsquare.com/article/rs-1317439/v1.html
Eye10.1038/s41433-018-0228-72018333419-427Choroidal morphology and short-term outcomes of combination photodynamic therapy in polypoidal choroidal vasculopathyJiwon Baek, Jae Hyung Lee, Sohee Jeon, Won Ki Leehttp://www.nature.com/articles/s41433-018-0228-7.pdf, http://www.nature.com/articles/s41433-018-0228-7, http://www.nature.com/articles/s41433-018-0228-7.pdf
Eye10.1038/eye.2013.17920132791013-1021Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathyM Inoue, A Arakawa, S Yamane, K Kadonosonohttp://www.nature.com/articles/eye2013179.pdf, http://www.nature.com/articles/eye2013179, http://www.nature.com/articles/eye2013179.pdf
Acta Ophthalmologica10.1111/j.1755-3768.2016.0456201694Short-term efficacy of intravitreal aflibercept depending on subtypes of polypoidal choroidal vasculopathy: polypoidal choroidal neovascularization or idiopathic choroidal vasculopathyM. Sagong, S. Jeonghttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2016.0456, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2016.0456/fullpdf
BMC Ophthalmology10.1186/s12886-022-02551-32022221Ethnic differences on long term outcomes of polypoidal choroidal vasculopathy after predominantly bevacizumab monotherapyAaron Yap, Nancy Wang, David Squirrellhttps://link.springer.com/content/pdf/10.1186/s12886-022-02551-3.pdf, https://link.springer.com/article/10.1186/s12886-022-02551-3/fulltext.html, https://link.springer.com/content/pdf/10.1186/s12886-022-02551-3.pdf
Eye10.1038/s41433-019-0387-120193371190-1191Comment on: Clinical outcomes in Caucasian patients with polypoidal choroidal vasculopathyH. D. Jeffry Hogg, S. James Talkshttp://www.nature.com/articles/s41433-019-0387-1.pdf, http://www.nature.com/articles/s41433-019-0387-1, http://www.nature.com/articles/s41433-019-0387-1.pdf
Eye10.1038/s41433-022-02251-82022Characteristics and treatment response of polypoidal choroidal vasculopathy in highly myopic eyesWei-Lun Huang, Yun Hsia, Shih-Wen Wang, Kuo-Chi Hung, Chien-Jung Huang, Muh-Shy Chen, Tzyy-Chang Hohttps://www.nature.com/articles/s41433-022-02251-8.pdf, https://www.nature.com/articles/s41433-022-02251-8, https://www.nature.com/articles/s41433-022-02251-8.pdf
Scientific Reports10.1038/s41598-021-86014-72021111Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathyHidetaka Matsumoto, Junki Hoshino, Ryo Mukai, Kosuke Nakamura, Hideo Akiyamahttps://www.nature.com/articles/s41598-021-86014-7.pdf, https://www.nature.com/articles/s41598-021-86014-7, https://www.nature.com/articles/s41598-021-86014-7.pdf
American Journal of Ophthalmology10.1016/j.ajo.2004.06.00720041384693-694Laser photocoagulation of indocyanine green aniographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathyTimothy Y.Y. Lai, Wai-Man Chan, Dennis S.C. Lamhttps://api.elsevier.com/content/article/PII:S0002939404006634?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0002939404006634?httpAccept=text/plain